Publications
- (+/-)-BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3 beta Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease2021 | Publication without faculty affiliation
- Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer's disease therapy2019 | Publication without faculty affiliation
- Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase2019 | Publication without faculty affiliation
- Profiling donepezil template into multipotent hybrids with antioxidant properties2018 | Publication without faculty affiliation
- The antioxidant additive approach for Alzheimer's disease therapy: New ferulic (Lipoic) acid plus melatonin modified tacrines as Cholinesterases inhibitors, direct antioxidants, and nuclear factor (Erythroid-Derived 2)-like 2 activators2016 | Publication without faculty affiliation
- Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities2022 | Faculty of Medicine in Hradec Králové
- Discovery of Dual A beta/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer's Disease2022 | Publication without faculty affiliation
- Tacrine - Benzothiazoles: Novel class of potential multitarget anti-Alzheimer's drugs dealing with cholinergic, amyloid and mitochondrial systems2021 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Huprine Y-Tryptophan heterodimers with potential implication to Alzheimer's disease treatment2021 | Faculty of Pharmacy in Hradec Králové, First Faculty of Medicine
- 2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease2021 | Publication without faculty affiliation
Loading network view...